6-fluoro-3-[4-(trifluoromethylsulfonyl)piperazin-1-yl]-1H-indole;4-(1H-indol-3-yl)-N,N-dimethylpiperazine-1-sulfonamide;1-[4-(1H-indol-3-yl)-2,2-dimethylpiperazin-1-yl]ethanone;1-[4-(1H-indol-3-yl)-2-methylpiperazin-1-yl]ethanone
C58H73F4N13O6S2 — CID 157312238
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-fluoro-3-[4-(trifluoromethylsulfonyl)piperazin-1-yl]-1H-indole;4-(1H-indol-3-yl)-N,N-dimethylpiperazine-1-sulfonamide;1-[4-(1H-indol-3-yl)-2,2-dimethylpiperazin-1-yl]ethanone;1-[4-(1H-indol-3-yl)-2-methylpiperazin-1-yl]ethanone
6-fluoro-3-[4-(trifluoromethylsulfonyl)piperazin-1-yl]-1H-indole;4-(1H-indol-3-yl)-N,N-dimethylpiperazine-1-sulfonamide;1-[4-(1H-indol-3-yl)-2,2-dimethylpiperazin-1-yl]ethanone;1-[4-(1H-indol-3-yl)-2-methylpiperazin-1-yl]ethanone (PubChem CID 157312238) has the molecular formula C58H73F4N13O6S2 and a molecular weight of 1188.43 g/mol. Its IUPAC name is 6-fluoro-3-[4-(trifluoromethylsulfonyl)piperazin-1-yl]-1H-indole;4-(1H-indol-3-yl)-N,N-dimethylpiperazine-1-sulfonamide;1-[4-(1H-indol-3-yl)-2,2-dimethylpiperazin-1-yl]ethanone;1-[4-(1H-indol-3-yl)-2-methylpiperazin-1-yl]ethanone.
Molecular Properties
| Compound Name | 6-fluoro-3-[4-(trifluoromethylsulfonyl)piperazin-1-yl]-1H-indole;4-(1H-indol-3-yl)-N,N-dimethylpiperazine-1-sulfonamide;1-[4-(1H-indol-3-yl)-2,2-dimethylpiperazin-1-yl]ethanone;1-[4-(1H-indol-3-yl)-2-methylpiperazin-1-yl]ethanone |
|---|---|
| PubChem CID | 157312238 |
| Molecular Formula | C58H73F4N13O6S2 |
| Molecular Weight | 1188.43 g/mol |
| Exact Mass | 1187.52 |
| IUPAC Name | 6-fluoro-3-[4-(trifluoromethylsulfonyl)piperazin-1-yl]-1H-indole;4-(1H-indol-3-yl)-N,N-dimethylpiperazine-1-sulfonamide;1-[4-(1H-indol-3-yl)-2,2-dimethylpiperazin-1-yl]ethanone;1-[4-(1H-indol-3-yl)-2-methylpiperazin-1-yl]ethanone |
| SMILES | CC(=O)N1CCN(c2c[nH]c3ccccc23)CC1(C)C.CC(=O)N1CCN(c2c[nH]c3ccccc23)CC1C.CN(C)S(=O)(=O)N1CCN(c2c[nH]c3ccccc23)CC1.O=S(=O)(N1CCN(c2c[nH]c3cc(F)ccc23)CC1)C(F)(F)F |
| InChI | InChI=1S/C16H21N3O.C15H19N3O.C14H20N4O2S.C13H13F4N3O2S/c1-12(20)19-9-8-18(11-16(19,2)3)15-10-17-14-7-5-4-6-13(14)15;1-11-10-17(7-8-18(11)12(2)19)15-9-16-14-6-4-3-5-13(14)15;1-16(2)21(19,20)18-9-7-17(8-10-18)14-11-15-13-6-4-3-5-12(13)14;14-9-1-2-10-11(7-9)18-8-12(10)19-3-5-20(6-4-19)23(21,22)13(15,16)17/h4-7,10,17H,8-9,11H2,1-3H3;3-6,9,11,16H,7-8,10H2,1-2H3;3-6,11,15H,7-10H2,1-2H3;1-2,7-8,18H,3-6H2 |
| InChIKey | BDEBFGDFCSWXOP-UHFFFAOYSA-N |
| XLogP | 8.21 |
| TPSA | 194.74 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 83 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1188.43 |
| LogP ≤ 5 | 8.21 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157312238 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.